Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

Objective To determine the diagnostic accuracy of serological tests for coronavirus disease-
2019 (covid-19). Design Systematic review and meta-analysis. Data sources Medline …

Zoonotic introduction of novel coronaviruses may encounter preexisting immunity in
humans. Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we …

Background Progress in characterising the humoral immune response to Severe Acute
Respiratory Syndrome 2 (SARS-CoV-2) has been rapid but areas of uncertainty persist …

SARS-CoV-2 is a novel coronavirus that is the causative agent of coronavirus infectious
disease 2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in …

the primary analysis is unfortunately common. In early phase studies in a pandemic, little is
known for certain, and it seems biologically plausible that treating patients earlier could be …

In late 2019, China reported a cluster of atypical pneumonia cases of unknown etiology in
Wuhan. The causative agent was identified as a new betacoronavirus, called severe acute …

Since emerging in China in December 2019, COVID-19 has spread globally, wreaked havoc
for public health and economies worldwide and, given the high infectivity and unexpectedly …

Effective and efficient management of human betacoronavirus severe acute respiratory
syndrome (SARS)-CoV-2 virus infection ie, COVID-19 pandemic, required sensitive and …

To the Editor—We welcome the first prospective study of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) household transmission in the United States (US) by Lewis …